Published in Crit Rev Eukaryot Gene Expr on January 01, 2010
Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol (2012) 1.66
Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms. Stem Cells Int (2015) 0.75
Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury. Front Physiol (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71
Bone resorption by osteoclasts. Science (2000) 11.68
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell (2008) 8.01
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 7.19
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet (2006) 7.05
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol (2004) 3.34
Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81
Circulating skeletal stem cells. J Cell Biol (2001) 2.58
Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res (2000) 2.37
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci (2003) 2.15
A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A (2003) 2.09
Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest (2002) 2.05
Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells (2007) 1.92
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A (2004) 1.82
Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol (2003) 1.76
The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am (1993) 1.67
Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am (1977) 1.65
Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol (2007) 1.62
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res (2008) 1.52
Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A (2003) 1.47
Circulating mesenchymal stem cells. Int J Biochem Cell Biol (2004) 1.43
Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg (2002) 1.38
Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol (1997) 1.37
Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A (1992) 1.36
Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest (1995) 1.36
Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg (2002) 1.34
Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells (2009) 1.33
Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells (2009) 1.32
Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun (2007) 1.32
Characterization of circulating osteoblast lineage cells in humans. Bone (2007) 1.27
Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation (2003) 1.26
Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci (2007) 1.22
Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype. Br J Haematol (2003) 1.16
Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum (2009) 1.13
Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells (2007) 1.10
CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch (2001) 1.09
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells. Bone (2008) 1.08
Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells (2000) 1.06
The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int (2002) 1.01
Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int J Biochem Cell Biol (2009) 1.00
Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J Surg (2003) 0.99
On the origin of cells in heterotopic bone formation. Clin Orthop Relat Res (1975) 0.97
CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch (2002) 0.97
A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis. Rheumatology (Oxford) (1999) 0.96
CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol (1994) 0.93
Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol (2001) 0.93
The Frank Stinchfield Award. Inhibition of heterotopic ossification with radiation therapy in an animal model. Clin Orthop Relat Res (1998) 0.90
Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone (2010) 0.86
Fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res (1997) 0.86
Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. Tissue Eng (2005) 0.83
Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med (2010) 4.88
Heterotopic ossification. J Am Acad Orthop Surg (2004) 2.96
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81
Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol (2008) 2.64
Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am (2009) 2.53
The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest (2009) 2.18
Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics (2008) 2.02
Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis (2011) 1.98
Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem (2008) 1.88
Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am (2007) 1.83
Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) (2005) 1.81
Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res (2008) 1.72
Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res (2007) 1.68
Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med (2013) 1.66
The face signature of fibrodysplasia ossificans progressiva. Am J Med Genet A (2012) 1.62
Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2008) 1.59
In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am (2003) 1.59
Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Eur J Pediatr (2010) 1.52
Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2010) 1.51
Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am (2003) 1.49
Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41
Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res (2005) 1.38
Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev (2013) 1.37
Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res (2006) 1.36
Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (2004) 1.35
Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells (2009) 1.32
A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther (2007) 1.30
Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem (2006) 1.30
Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci (2007) 1.22
Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem (2011) 1.21
Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva. Ann N Y Acad Sci (2006) 1.19
Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech (2012) 1.18
An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res (2012) 1.17
The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev (2009) 1.11
Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells (2014) 1.02
In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs (2011) 0.95
CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol (2012) 0.95
High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann Biomed Eng (2008) 0.94
Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (2003) 0.94
Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J Bone Miner Res (2011) 0.94
When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov Today Ther Strateg (2008) 0.94
HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells. J Cell Biochem (2007) 0.92
Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol (2012) 0.89
Progressive osseous heteroplasia in the face of a child. Am J Med Genet A (2003) 0.89
Over-expression of BMP4 and BMP5 in a child with axial skeletal malformations and heterotopic ossification: a new syndrome. Am J Med Genet A (2007) 0.88
Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis. Ann N Y Acad Sci (2011) 0.87
Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva. Methods Enzymol (2010) 0.85
Derailing heterotopic ossification and RARing to go. Nat Med (2011) 0.84
Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report. Bone (2006) 0.84
Reported noggin mutations are PCR errors. Am J Med Genet (2002) 0.84
The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases. Bone (2013) 0.82
Chin-on-chest deformity in patients with fibrodysplasia ossificans progressiva. A case series. J Bone Joint Surg Am (2009) 0.81
Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo. Stem Cells (2012) 0.81
Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva. J Neurosurg Pediatr (2008) 0.80
Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs. Bone (2013) 0.79
Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia. J Clin Invest (2013) 0.79
Severe soft tissue ossification in a southern right whale Eubalaena australis. Dis Aquat Organ (2012) 0.78
Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs. J Bone Miner Res (2014) 0.78
The immunological contribution to heterotopic ossification disorders. Curr Osteoporos Rep (2015) 0.76
Viewing FOP through rosi-colored glasses. J Bone Miner Res (2010) 0.75
Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance. PLoS One (2012) 0.75
Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (2003) 0.75
Focal fibronodular heterotopic ossification. A case report. J Bone Joint Surg Am (2007) 0.75